Hantz Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MMEA
Hantz Financial Services's ARKG Position: Q2 2024 in Review
Hantz Financial Services sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 150 shares — an estimated $4K sold.
Hantz Financial Services first reported a position in ARKG in Q4 2023 and held it in 2 quarters. The position peaked at $5K in Q4 2023. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.
- Hantz Financial Services reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
- Hantz Financial Services sold 150 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $4K.
- Hantz Financial Services first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 2 quarters.
- Hantz Financial Services's ARK Genomic Revolution ETF position peaked at $5K in Q4 2023.
- 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.
Based on Hantz Financial Services's 13F filing for Q2 2024, filed 30 Jul 2024.